WVE
Companies
NASDAQ
Wave Life Sciences Ltd.
Health Care
$6.90
-$5.47 (-44.22%)
Price Chart
Overview
About WVE
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
Market Cap
$711.5M
Volume
9.5M
Avg. Volume
11.1M
P/E Ratio
-6.673469
Dividend Yield
0.00%
Employees
283.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.60
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, WVE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$711.5M
Volume9.5M
P/E Ratio-6.67
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025